Literature DB >> 22278254

Differential Gag-specific polyfunctional T cell maturation patterns in HIV-1 elite controllers.

Sara Ferrando-Martínez1, Joseph P Casazza, Manuel Leal, Kawthar Machmach, Ma Ángeles Muñoz-Fernández, Pompeyo Viciana, Richard A Koup, Ezequiel Ruiz-Mateos.   

Abstract

A small fraction of HIV-infected individuals (<1%), referred to as elite controllers (EC), are able to maintain undetectable viral loads indefinitely without treatment. The role of the maturational phenotype of T cells in the control of HIV infection in these individuals is not well described. We compared the maturational and functional phenotypes of Gag-specific CD4 and CD8 T cells from EC, who maintain undetectable viral loads without treatment; relative controllers (RC), who maintain viral loads of <1,000 copies/ml without treatment; and noncontrollers (NC), who fail to control viral replication. EC maintained higher frequencies of HIV-specific CD4 T cells, less mature polyfunctional Gag-specific CD4 T cells (CD27(+) CD57(-) CD45RO(+)), and Gag-specific polyfunctional CD4 T cells than those observed in NC. In EC, the frequency of polyfunctional Gag-specific CD8 T cells was higher than that observed in RC and NC. RC had a similar functional phenotype to that observed in NC, despite consistently lower viral loads. Finally, we found a direct correlation between the frequency of Gag-specific CD27(+) CD57(-) CD45RO(+) CD4(+) T cells and the frequency of mature HIV-specific CD8 T cells. Altogether, our data suggest that immature Gag-specific interleukin-2 (IL-2)-producing CD4(+) T cells may play an important role in spontaneous control of HIV viremia by effectively supporting HIV-specific CD8 T lymphocytes. This difference appears to differentiate EC from RC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22278254      PMCID: PMC3302538          DOI: 10.1128/JVI.07034-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha.

Authors:  Mathias Lichterfeld; Xu G Yu; Michael T Waring; Stanley K Mui; Mary N Johnston; Daniel Cohen; Marylyn M Addo; John Zaunders; Galit Alter; Eunice Pae; Daryld Strick; Todd M Allen; Eric S Rosenberg; Bruce D Walker; Marcus Altfeld
Journal:  Blood       Date:  2004-04-01       Impact factor: 22.113

2.  Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro.

Authors:  J F Krowka; D P Stites; S Jain; K S Steimer; C George-Nascimento; A Gyenes; P J Barr; H Hollander; A R Moss; J M Homsy
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

3.  Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment.

Authors:  Brinda Emu; Elizabeth Sinclair; David Favre; Walter J Moretto; Priscilla Hsue; Rebecca Hoh; Jeffrey N Martin; Douglas F Nixon; Joseph M McCune; Steven G Deeks
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.

Authors:  Olivier Lambotte; Faroudy Boufassa; Yoann Madec; Ahn Nguyen; Cécile Goujard; Laurence Meyer; Christine Rouzioux; Alain Venet; Jean-François Delfraissy
Journal:  Clin Infect Dis       Date:  2005-08-30       Impact factor: 9.079

5.  Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group.

Authors:  D Candotti; D Costagliola; C Joberty; O Bonduelle; C Rouzioux; B Autran; H Agut
Journal:  J Med Virol       Date:  1999-07       Impact factor: 2.327

6.  Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection.

Authors:  B Wahren; L Morfeldt-Månsson; G Biberfeld; L Moberg; A Sönnerborg; P Ljungman; A Werner; R Kurth; R Gallo; D Bolognesi
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

7.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

Authors:  S A Migueles; M S Sabbaghian; W L Shupert; M P Bettinotti; F M Marincola; L Martino; C W Hallahan; S M Selig; D Schwartz; J Sullivan; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

8.  Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.

Authors:  Stephen A Migueles; Christine M Osborne; Cassandra Royce; Alex A Compton; Rohan P Joshi; Kristin A Weeks; Julia E Rood; Amy M Berkley; Jonah B Sacha; Nancy A Cogliano-Shutta; Margaret Lloyd; Gregg Roby; Richard Kwan; Mary McLaughlin; Sara Stallings; Catherine Rehm; Marie A O'Shea; JoAnn Mican; Beverly Z Packard; Akira Komoriya; Sarah Palmer; Ann P Wiegand; Frank Maldarelli; John M Coffin; John W Mellors; Claire W Hallahan; Dean A Follman; Mark Connors
Journal:  Immunity       Date:  2008-12-08       Impact factor: 31.745

9.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Authors:  Victor Appay; P Rod Dunbar; Margaret Callan; Paul Klenerman; Geraldine M A Gillespie; Laura Papagno; Graham S Ogg; Abigail King; Franziska Lechner; Celsa A Spina; Susan Little; Diane V Havlir; Douglas D Richman; Norbert Gruener; Gerd Pape; Anele Waters; Philippa Easterbrook; Mariolina Salio; Vincenzo Cerundolo; Andrew J McMichael; Sarah L Rowland-Jones
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

10.  HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity.

Authors:  Souheil-Antoine Younes; Bader Yassine-Diab; Alain R Dumont; Mohamed-Rachid Boulassel; Zvi Grossman; Jean-Pierre Routy; Rafick-Pierre Sekaly
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  29 in total

1.  HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.

Authors:  B Dominguez-Molina; L Tarancon-Diez; S Hua; C Abad-Molina; E Rodriguez-Gallego; K Machmach; F Vidal; C Tural; S Moreno; J M Goñi; E Ramírez de Arellano; M Del Val; M F Gonzalez-Escribano; J Del Romero; C Rodriguez; L Capa; P Viciana; J Alcamí; X G Yu; B D Walker; Manuel Leal; M Lichterfeld; E Ruiz-Mateos
Journal:  Clin Infect Dis       Date:  2016-12-16       Impact factor: 9.079

2.  IFNγ⁻TNFα⁻IL2⁻MIP1α⁻CD107a⁺PRF1⁺ CD8 pp65-Specific T-Cell Response Is Independently Associated With Time to Death in Elderly Humans.

Authors:  Sara Ferrando-Martínez; Ezequiel Ruiz-Mateos; Joseph P Casazza; Rebeca S de Pablo-Bernal; Beatriz Dominguez-Molina; M Ángeles Muñoz-Fernández; Juan Delgado; Rafael de la Rosa; Rafael Solana; Richard A Koup; Manuel Leal
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-09-18       Impact factor: 6.053

3.  FOXO3 regulates the CD8 T cell response to a chronic viral infection.

Authors:  Jeremy A Sullivan; Eui Ho Kim; Erin H Plisch; M Suresh
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

4.  Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.

Authors:  María Pernas; Laura Tarancón-Diez; Cecilio Lopez-Galindez; Ezequiel Ruiz-Mateos; Esther Rodríguez-Gallego; Josep Gómez; Julia G Prado; Concepción Casado; Beatriz Dominguez-Molina; Isabel Olivares; Maite Coiras; Agathe León; Carmen Rodriguez; Jose Miguel Benito; Norma Rallón; Montserrat Plana; Onofre Martinez-Madrid; Marta Dapena; Jose Antonio Iribarren; Jorge Del Romero; Felipe García; José Alcamí; MaÁngeles Muñoz-Fernández; Francisco Vidal; Manuel Leal
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

5.  Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.

Authors:  Gabriela Turk; Yanina Ghiglione; Juliana Falivene; María Eugenia Socias; Natalia Laufer; Romina Soledad Coloccini; Ana María Rodriguez; María Julia Ruiz; María Ángeles Pando; Luis David Giavedoni; Pedro Cahn; Omar Sued; Horacio Salomon; María Magdalena Gherardi
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

6.  Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.

Authors:  Gerald K Chege; Wendy A Burgers; Helen Stutz; Ann E Meyers; Rosamund Chapman; Agano Kiravu; Rubina Bunjun; Enid G Shephard; William R Jacobs; Edward P Rybicki; Anna-Lise Williamson
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

7.  Cytotoxic CD8+ T Cells Expressing CXCR5 Are Detectable in HIV-1 Elite Controllers After Prolonged In Vitro Peptide Stimulation.

Authors:  Philipp Adams; Gilles Iserentant; Jean-Yves Servais; Linos Vandekerckhove; Guido Vanham; Carole Seguin-Devaux
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

Review 8.  The impact of differential antiviral immunity in children and adults.

Authors:  Andrew J Prendergast; Paul Klenerman; Philip J R Goulder
Journal:  Nat Rev Immunol       Date:  2012-09       Impact factor: 53.106

9.  Effects of therapeutic vaccination on the control of SIV in rhesus macaques with variable responsiveness to antiretroviral drugs.

Authors:  Hillary Claire Tunggal; Paul Veness Munson; Megan Ashley O'Connor; Nika Hajari; Sandra Elizabeth Dross; Debra Bratt; James Thomas Fuller; Kenneth Bagley; Deborah Heydenburg Fuller
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

10.  Evaluating cellular polyfunctionality with a novel polyfunctionality index.

Authors:  Martin Larsen; Delphine Sauce; Laurent Arnaud; Solène Fastenackels; Victor Appay; Guy Gorochov
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.